Construction of expressing vectors including melanoma differentiation-associated gene-۷ (mda-۷) fused with the RGD sequences for better tumor targeting

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 33

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-18-8_008

تاریخ نمایه سازی: 23 اسفند 1402

Abstract:

Objective(s): Up to now, many researches have been performed to improve the antitumoral effect of melanoma differentiation-associated gene-۷ (mda-۷) protein. The purpose of our research was to construct ۳ expression vectors producing mda-۷ in fusion with RGD (Arginine-Glycine-Aspartic acid) peptide and evaluate their expression.     Materials and Methods: mda-۷ gene with two different RGD sequences was amplified by PCR then was cloned by TA–cloning system. The colonies including these genes were selected by blue–white screening, colony PCR, and sequencing, respectively. Afterward, the genes were sub-cloned into the expression vector following confirmation by colony PCR and sequencing. In addition, these constructs were transfected into ۲۹۳ and Huh-۷ cells for further expression analysis. The mda-۷ gene expression was evaluated by RT-PCR and IF (immunofluorescence assay). DNA laddering test and trypan blue exclusion assays were performed to screen cytotoxicity of prepared plasmids. Results: Three different mda-۷ genes with terminal RGD peptide were cloned correctly into the expression vectors and their expression was confirmed to be suitable by RT-PCR and IF assay. It was shown that expressions were limited to those transfected, GFP shining cells. No significant cytotoxicity was observed by simple assays in all plasmid treated cells. In expressing cells, all forms of mda-۷ protein were localized mainly around ER prenuclear compartment while GFP protein was distributed evenly among them. Conclusion: Theoretically RGD tagged mda-۷ would be able to induce apoptosis with more specificity and stronger than the standard one, therefore, these new constructs may have the potential for further researches.

Authors

Mahboobeh Khodadad

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Seyed Younes Hosseini

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Fatemeh Shenavar

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Nasrollah Erfani

Cancer Immunology Research Group, Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Samaneh Bina

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Shahin Ahmadian

Sciences Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran

Mohammad-Reza Fattahi

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Reza Hajhosseini

Department Of Biochemistry, Payame Noor University, Tehran Shargh Branch, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Fisher P.B. Is mda-۷/IL-۲۴ a magic bullet for cancer? Cancer ...
  • Xue XB, Xiao Ch Wen, Zhang H, Lu AG, Gao ...
  • Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, ...
  • Sarkar D, Su Z-Z, Lebedeva IV, Sauane M, Gopalkrishnan RV, ...
  • Mhashilkar AM, Schrock RD, Hindi M, Liao J, Sieger K, ...
  • Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, ...
  • Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, ...
  • Cao XX I, Mohuiddin S, Chada AM, Mhashilkar MK, Ozvaran ...
  • Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, ...
  • Weber WA, Haubner R, Vabuliene E, Kuhnast B, Wester HJ,Schwaiger ...
  • Wang M, Tan Z, Zhang R, Kotenko SV, Liang P. ...
  • Sauane M, Su Z-z, Gupta P, Lebedeva IV, Dent P, ...
  • Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, ...
  • Liu JJ, Zhang BF, Yin XX, Pei DS, Yang ZX, ...
  • Jin H, Varner J. Integrins: roles in cancer development and ...
  • Zitzmann S, Ehemann V, Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds ...
  • Kumar cc. Integrin alpha v beta ۳ as a therapeutic ...
  • Xiao B, Li W, Yang J, Guo G, Mao X-H, ...
  • Pei D-S, Yang Z-X, Zhang B-F, Yin X-X, Li L-T, ...
  • Craig R, Cutrera J, Zhu S, Xia X, Lee Y-H, ...
  • Wang X, Bai C, Zhang J, Sun A, Wang X, ...
  • Kreis S, Philippidou D, Margue C, Rolvering C, Haan C, ...
  • Temming K, Schiffelers RM, Molema G, Kok RJ. RGD-based strategies ...
  • Momtazi-borojeni Aa, Behbahani M, Sadeghi-aliabadi H. Antiproliferative activity and apoptosis ...
  • Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, ...
  • Wang CJ, Xue XB, Yi JL, Chen K, Zheng JW, ...
  • Chen WY, Cheng YT, Lei HY, Chang CP, Wang CW, ...
  • Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. ...
  • Jin ZH, Furukawa T, Claron M, Boturyn D, Coll JL, ...
  • نمایش کامل مراجع